Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Friday, February 4, 2011

Baclofen for alcohol withdrawal.



In recent years, baclofen demonstrated its ability to reduce symptoms of severe alcohol withdrawal syndrome (AWS) in alcoholic patients, without producing any significant side effects. 

This review attempted to evaluate if baclofen is generally effective and safe as a therapy for AWS. 

Among the pertinent literature, there was only one study meeting our inclusion criteria. In general, baclofen is efficacious, safe and well tolerated for the treatment of AWS. 

The evidence of recommending baclofen for AWS is insufficient. 

More well designed randomised controlled clinical trials (RCTs) are demanded to further prove its efficacy and safety.


Read Full Abstract